Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001220 · ClinicalTrials.gov registry record

Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders

A clinical trial of Motor Neuron Disease and Deglutition Disorder, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
750
Enrollment target
1
Study location

NCT00001220 is a study of Motor Neuron Disease and Deglutition Disorder that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 750 participants, above the 486-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001220, a study of Motor Neuron Disease and Deglutition Disorder, has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
750 participants
Enrollment target
1
Study location

Study Summary

This study will identify clinical signs and symptoms critical for diagnosing swallowing disorders and will characterize swallowing problems in various patient populations, such as patients with Parkinson's disease, stroke, post-polio syndrome, multiple sclerosis and other conditions that cause swallowing abnormalities. Patients with swallowing difficulties who are enrolled in NIH neurology or speech pathology protocols may be eligible for this study. Participants will undergo the following procedures: 1. Oral examination-A neurologist and speech pathologist examine the patient's swallowing function. The patient is interviewed about difficulties with food intake, chewing and swallowing during meals. 2. Ultrasound examination-Ultrasound creates image of areas inside the body using sound waves. With the patient in a sitting position, a 3/4-inch transducer (device for transmitting and receiving sound waves) is placed under the chin to visualize tongue movements during swallowing. 3. Modified barium swallow-While standing or sitting, the patient swallows 1/2 teaspoon of flavored barium (a radioactive substance) six times (a total of 3 teaspoons), while the tongue and pharynx (tube leading from the mouth to the esophagus) are scanned and videotaped. The barium is given in three consistencies-thin, medium and thick (pudding-like). 4. Electromyography-A small plastic strip with wires attached is placed under the patient's chin. The patient then swallows 1/2 ounce of barium three times in a row, and the movement of the chin muscles during swallowing is displayed. Patients may also be asked to swallow 5/8 cup of barium twice; once with the head tilted upward and once with the head untilted. Depending on the test results, patients may be asked to return for follow-up study and monitoring.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center (CC) - Bethesda

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 1987-10
Est. Completion 2005-11

What the Registry Record Tells You About NCT00001220

The ClinicalTrials.gov registry entry for NCT00001220 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 486-participant average among 17 other Motor Neuron Disease trials with a reported enrollment target (54% higher). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Motor Neuron Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00001220 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001220 about?

NCT00001220 is a clinical study titled "Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders". This study will identify clinical signs and symptoms critical for diagnosing swallowing disorders and will characterize swallowing problems in various patient populations, such as patients with Parkinson's disease, stroke, post-polio syndrome, multiple sclerosis and other conditions that cause swall...

What is the current status of trial NCT00001220?

This trial is currently completed. The enrollment target is 750 participants. The study started on 1987-10. Estimated completion is 2005-11.

What conditions does trial NCT00001220 study?

This clinical trial studies the following conditions: Motor Neuron Disease, Deglutition Disorder.

Who is sponsoring clinical trial NCT00001220?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001220 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Motor Neuron Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.